ANKFN1 | Ankyrin-repeat and fibronectin type III domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKK1 | Ankyrin repeat and kinase domain containing 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD20A2 | Ankyrin repeat domain 20 family, member A2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD20A4 | Ankyrin repeat domain 20 family, member A4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD22 | Ankyrin repeat domain 22 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD29 | Ankyrin repeat domain 29 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ANKRD30A | Ankyrin repeat domain 30A | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD33B | Ankyrin repeat domain 33B | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD34B | Ankyrin repeat domain 34B | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD35 | Ankyrin repeat domain 35 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD42 | Ankyrin repeat domain 42 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD53 | Ankyrin repeat domain 53 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKRD65 | Ankyrin repeat domain 65 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKS4B | Ankyrin repeat and sterile alpha motif domain containing 4B | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANLN | Anillin, actin binding protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANO2 | Anoctamin 2, calcium activated chloride channel | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO3 | Anoctamin 3 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ANO5 | Anoctamin 5 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
ANO7 | Anoctamin 7 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANO9 | Anoctamin 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ANXA2R | Annexin A2 receptor | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANXA8 | Annexin A8 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANXA8L1 | Annexin A8-like 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AOAH | Acyloxyacyl hydrolase (neutrophil) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AP000349.2 | PP13850 {ECO:0000313|EMBL:AAQ15253.1} | Predicted intracellular proteins
| | | | | Tissue enhanced |
AP000350.10 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000400325} | Predicted membrane proteins
| | | | | Tissue enhanced |
APBA1 | Amyloid beta (A4) precursor protein-binding, family A, member 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
APBB3 | Amyloid beta (A4) precursor protein-binding, family B, member 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
APCDD1 | Adenomatosis polyposis coli down-regulated 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APCDD1L | Adenomatosis polyposis coli down-regulated 1-like | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
APELA | Apelin receptor early endogenous ligand | Predicted secreted proteins
| | | | | Tissue enhanced |
APITD1-CORT | APITD1-CORT readthrough | Predicted intracellular proteins
| | | | | Tissue enhanced |
APLN | Apelin | Predicted intracellular proteins
| | | | | Tissue enhanced |
APLNR | Apelin receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | Predicted intracellular proteins
| | | | | Tissue enhanced |
APOBEC3B | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B | Predicted intracellular proteins
| | | | | Tissue enhanced |
APOD | Apolipoprotein D | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APOLD1 | Apolipoprotein L domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
AQP11 | Aquaporin 11 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AQP9 | Aquaporin 9 | Predicted membrane proteins
| | | | | Tissue enhanced |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
AREG | Amphiregulin | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGAP11B | Rho GTPase activating protein 11B | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGAP15 | Rho GTPase activating protein 15 | Predicted intracellular proteins
| | | | | Tissue enhanced |